American Journal of Cardiology
Volume 105, Issue 8 , Pages 1147-1152 , 15 April 2010

Determinants of Adiponectin Levels in Patients With Chronic Systolic Heart Failure

  • Andreia Biolo, MD, ScD

      Affiliations

    • Division of Cardiology, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
    • ,
  • Rei Shibata, MD, PhD

      Affiliations

    • Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts
    • ,
  • Noriyuki Ouchi, MD, PhD

      Affiliations

    • Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts
    • ,
  • Shinji Kihara, MD, PhD

      Affiliations

    • Department of Metabolic Medicine, Osaka University, Osaka, Japan
    • ,
  • Mina Sonoda, BS

      Affiliations

    • Department of Metabolic Medicine, Osaka University, Osaka, Japan
    • ,
  • Kenneth Walsh, PhD

      Affiliations

    • Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts
    • ,
  • Flora Sam, MD

      Affiliations

    • Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts
    • Section of Cardiovascular, Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: (617) 638-8072; fax: (617) 638-4066

Received 8 October 2009 ,Revised 3 December 2009 ,Accepted 3 December 2009.

References 

  1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746–26749
  2. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10:1384–1389
  3. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43:1318–1323
  4. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–1599
  5. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85–89
  6. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112:1756–1762
  7. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart. 2006;92:1420–1424
  8. Haugen E, Furukawa Y, Isic A, Fu M. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol. 2008;125:216–219
  9. Takano HObata Je, Kodama Y, Kitta Y, Nakamura T, Mende AKawabata Ki, Saito Y, et al. Adiponectin is released from the heart in patients with heart failure. Int J Cardiol. 2009;132:221–226
  10. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2599–2606
  11. Biolo A, Ramamurthy S, Connors LH, O'Hara CJ, Meier-Ewert HK, Soo Hoo PT, et al. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circ Heart Fail. 2008;1:249–257
  12. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83
  13. Osei K, Gaillard T, Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Rev. 2005;13:179–185
  14. Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf). 2004;61:332–338
  15. Yaturu S, Daberry RP, Rains J, Jain S. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokines. 2006;34:219–223
  16. Nakamura T, Funayama H, Kubo N, Yasu T, Kawakami M, Saito M, et al. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J. 2006;70:1557–1562
  17. Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf). 2003;58:22–29
  18. Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O'Brien PE, Dixon JB, et al. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab. 2005;90:3665–3672
  19. Kirpichnikov D, McFarlane SI, Sowers JR. Heart failure in diabetic patients: utility of beta-blockade. J Card Fail. 2003;9:333–344
  20. Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J. 2008;29:649–657
  21. Yamaji M, Tsutamoto T, Tanaka T, Kawahara C, Nishiyama K, Yamamoto T, et al. Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure. Circ J. 2009;73:1067–1073
  22. Tsutamoto T, Tanaka T, Sakai H, Ishikawa C, Fujii M, Yamamoto T, et al. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J. 2007;28:1723–1730
  23. Flynn KE, Pina IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451–1459
  24. Van Berendoncks AM, Beckers P, Hoymans VY, Possemiers N, Wuyts FL, Vrints CJ, Conraads VM. Exercise training reduces circulating adiponectin levels in patients with chronic heart failure. Clin Sci (Lond) Epub 2009 Aug 6.
  25. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol. 2009;53:2070–2077
  26. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in bloodstream and adipose tissue. Circulation. 2003;107:671–674
  27. Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl. 2003;84:S98–S102
  28. Skurk C, Wittchen F, Suckau L, Witt H, Noutsias M, Fechner H, et al. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J. 2008;29:1168–1180
  29. Mullen KL, Smith AC, Junkin KA, Dyck DJ. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. Am J Physiol Endocrinol Metab. 2007;293:E83–E90
  30. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, Lodish HF. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J. 2008;416:161–177

 This work was supported by grants HL-04423 and HL-079099 to Dr. Sam from the National Heart, Lung, and Blood Institute, Bethesda, Maryland; additional support was provided by an American Heart Association Postdoctoral Fellowship Award, Northeast Affiliate, Baltimore, Maryland to Dr. Shibata and a grant from the American Heart Association Scientist Development, Northeast Affiliate, Baltimore, Maryland to Dr. Ouchi.

PII: S0002-9149(09)02845-8

doi: 10.1016/j.amjcard.2009.12.015

American Journal of Cardiology
Volume 105, Issue 8 , Pages 1147-1152 , 15 April 2010

Article Tools

* Image Usage & Resolution